Anthony Elston Zamora

9PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 07, 2026
Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.

|Aug 23, 2025
SATB1 is a key regulator of quiescence in stem-like CD8+ T cells.

Siying Lin, Hongshen Niu, Yuqi Zhang

|Mar 31, 2025
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma.

Nirav N Shah, Alfredo S Colina, Bryon D Johnson

|Feb 12, 2025
Intestinal epithelium-derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease.

Aditya Rayasam, Alison Moe, Matthew Kudek

|Feb 04, 2022
Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation.

Ardiana Moustaki, Jeremy Chase Crawford, Shanta Alli

|Sep 08, 2021
Activation status dictates the function of unlicensed natural killer cells in mice and humans.

Ethan G Aguilar, Cordelia Dunai, Sean J Judge

Pageof 2

Frequent Collaborators

3 joint publications

Jeremy Chase Crawford

3 joint publications

Paul G Thomas

3 joint publications

Ravi K Shah

2 joint publications

William R Drobyski